This event is being delivered in partnership with Roche Diagnostics.
This webinar focuses on the exciting advancements in AI-driven digital pathology. We believe this is a critical area for discussion, particularly how it can enable high-volume, high-quality scanning and ultimately enhance patient care through rapid and accurate diagnoses. Specifically, we feel that the EYE-CAN-AID study serves as a powerful and highly relevant example to illustrate the practical impact and benefits of these technologies.
This event will take place at 12:30pm and last approximately 1 hour.
CPD
This meeting is worth 1 CPD point (self credited).
Our speaker
Professor Sarah Coupland
Prof. Sarah Coupland is a senior Consultant Histopathologist at the Liverpool University Foundation Hospital Trusts, UK, with expertise in ophthalmic pathology, haematopathology, molecular and digital pathology, and Biobanking.
In 2006, Prof. Coupland established the ‘Liverpool-Ocular-Oncology-Research-Group’ (www.loorg.org), a multidisciplinary team, focussing on ocular melanomas, lymphomas, and other eye cancers. She is the ‘George Holt Chair of Pathology’ at the University of Liverpool (UoL) (>2013). She leads Digital Pathology at the UoL, and has been involved in several multicentre DigPath and AI-related projects, particularly in eye cancers.
Prof. Coupland is the current President of the “Pathological Society of Great Britain and Ireland”. She is also Registrar of the Royal College of Pathologists.
She has published ~350 scientific articles (H-index:64/Scopus), has written ~150 Chapters, including some within the UICC/TNM Staging system for Ophthalmic Tumours, as well as the WHO ‘Blue’ Tumour Volumes (Eye, Haematopathology, Skin and Paediatric cancers).
She has won several awards for research and teaching, including the International Council of Ophthalmology's ‘Eye Pathology Award’ & the 2019 RCPath Excellence Award. She was included in the “Pathologist Power Lists” of 2019, 2020, 2021 and 2023, and was also listed in the “Top 100 Influential Women in Ophthalmology” in 2021 and 2024.
Prof Coupland was awarded an Honorary Fellowship of the Royal College of Ophthalmologists (FRCOphth) in 2023, for her significant contributions to Ophthalmic Pathology.
Our Chair
Matthew Johnson is Director of Access & Innovation at Roche Diagnostics Ltd.
With over 20 year’s commercial experience, Matt has a proven track record of leadership, building high performing teams and fostering collaboration. He is passionate about strengthening partnerships to drive meaningful change and improve healthcare outcomes.
Matt began his career at Roche in 2002 as part of a graduate program and has since held multiple leadership positions across the UK and Ireland. He is currently the Director of Access and Innovation (A&I), overseeing Medical Affairs, Public Affairs, Market Access, Health Economics, and two strategic functions - Business Development and Innovation.
Born and educated in Yorkshire, Matt studied Business & Marketing at Leeds University before embarking on his professional career in the healthcare industry. He is driven by the transformative impact that advances in healthcare can have on patient outcomes and is inspired by the opportunity to empower colleagues to grow, succeed, and contribute to meaningful change together.
Beyond his commercial and leadership achievements, Matt is passionate about leadership development and actively contributes to Roche’s leadership programs.
